From the field
A close call with malaria
By Mbarwa Kivuyo, Communications Officer, Ifakara Health Institute, Dar es Salaam, Tanzania
Malaria is a disease of the poor. A poor family cannot afford a decent home. A poor family cannot afford good treatment. In Tanzania, one of the least developed countries in Africa, virtually no family has escaped the reach of malaria.
At the age of 14, I nearly died of malaria. My father was a ward attendant in a village dispensary, so he kept different drugs at home. One day my mother observed in me the telltale signs of the onset of malaria. Out of ignorance, she overdosed me with chloroquine drugs, the first-line treatment for malaria in Tanzania in those years. After noticing that my condition was rapidly weakening, she grabbed a calabash full of fresh milk and gave it to me to drink as she spoke soothing words to the spirits. I was lucky—the milk made me vomit and relieved me from the overdose. My mother didn’t recognize that it was the fresh milk that saved me. She thought the gods had intervened. I will never forget this experience and the impact malaria has on so many lives in Tanzania.
If a vaccine were available, the malaria landscape of Tanzania would certainly change. Tanzanian children would be healthier, human labor productivity would increase, and performance in schools would improve. And perhaps the spirits could take a rest.
- Slide show: Photos from RTS,S Phase 3 trial sites
- Fact sheet: The PATH Malaria Vaccine Initiative (206 KB PDF)
- Fact sheet: RTS,S malaria vaccine candidate (269 KB PDF)
- Fact sheet: Preparing for a future malaria vaccine in Africa: The Malaria Vaccine Decision-Making Framework (186 KB PDF)
John-Michael Maas, Darby Communications